Tembo Global Industries Regulatory Approval

Convertible Warrants

Tembo Global Industries Convertible Warrants

Tembo Global obtained NSE trading approval for 40,50,000 equity shares of ₹1 each arising from warrant conversion. The shares will list from October 26, 2026.

Preferential Issue

Tembo Global Industries Preferential Issue

Tembo Global corrected post-preferential shareholding percentages for three proposed allottees in its EGM notice and corrigendum. The corrected figures supersede earlier disclosures; no other terms change.

Capacity Expansion

Tembo Global Industries Capacity Expansion

Tembo Global's subsidiary inaugurated a new defence-products factory unit in Amravati on 22 Oct 2026. No production-start date or capex figure was disclosed.

Other Announcement

Tembo Global Industries Other Announcement

Tembo Global Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a standard regulatory disclosure under Regulation 31.

Management Change

Tembo Global Industries Management Change

Mr. Harshal Patil has resigned from his position as Company Secretary and Compliance Officer of Tembo Global Industries Limited, effective from October 9, 2026.

Other Announcement

Tembo Global Industries Other Announcement

Tembo Global Industries intimated October 15, 2026 as the BSE main board listing date. The listing ceremony will be held on that date.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.